The Alzheimer’s disease market is anticipated to grow at an annualized rate of over 13%, till 2030, claims Roots Analysis
Roots
Analysis
has announced the addition of “Alzheimer's
Disease Market (2nd Edition), 2021-2031” report to
its list of offerings.
Limited treatment
options and unmet needs are the key drivers of research activity in this domain.
Several industry and non-industry players are presently engaged in developing
various types of disease modifying interventions and drug / therapy candidates
that offer symptomatic relief. Moreover, multiple venture capital firms and
other strategic investors have been supporting the research related initiatives
of various start-ups. Driven by a rich development pipeline and the efforts of
various stakeholders, the market is anticipated to grow at a significant pace in
the coming future.
To order this 150+
page report, which features 90+ figures, please visit
https://www.rootsanalysis.com/reports/view_document/alzheimers-disease-market/247.html
Key Market Insights
More than 240 drug
candidates for the treatment of Alzheimer’s
disease and associated symptoms are currently being investigated
Over 90% of the
therapies are being evaluated across preclinical and clinical stages, either as
monotherapies or in combination with other products. Majority of the drugs (60%)
are designed for oral administration.
190,000+ patients have been enrolled in over 2,000 clinical
trials, worldwide
Clinical research
activity, in terms of number of trials registered, is reported to have
increased at a CAGR of around 40% in the last five years. Of the total number
of trials, close to 65% have already been completed, while 25% are active and
still recruiting patients.
Close to 20,000
articles focused on Alzheimer’s disease and related symptoms have been
published since 2017
Several industry and
non-industry players engaged in this domain are undertaking numerous
initiatives to identify and develop novel therapies for this neurodegenerative
condition. Majority (81%) of the articles published by authors affiliated to
deemed universities are focused on studying the disease pathology.
Several partnerships
were established in this domain, during the period 2017-2021
Maximum number of
partnerships were observed to be inked in 2018, indicating a recent rise in the
interest of various players engaged in this domain. Majority of the deals were
reported to be research and development agreements, representing over 34% of
the total number of instances.
To request a sample
copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/view_document/alzheimers-disease-market/247.html
Key Questions
Answered
§
Who are the leading industry players involved in the
Alzheimer’s disease industry?
§
Which geographies are the most active in conducting
clinical trials on therapies for Alzheimer’s disease?
§
Which are the leading funding organizations providing
grants in the Alzheimer’s disease industry?
§
Which partnership models are commonly adopted by industry
stakeholders in the Alzheimer’s disease industry?
§
How is the current and future market opportunity, related
to Alzheimer’s disease, likely to be distributed across key market segments?
The financial
opportunity within the Alzheimer’s
disease market size has been analyzed across the following segments:
§ Type of Treatment
- Symptomatic
Treatment
- Disease
Modifying Treatment
§ Type of Symptomatic Indications
- Dementia
- Insomnia
- Other
Psychological Symptoms
§ Key Geographical Regions
- North
America
- Europe
- Asia-Pacific
and RoW’
The report features
inputs from eminent industry stakeholder(s), who were very optimistic
concerning the adoption of display library technologies. The report includes
detailed transcripts of the discussions held with the following industry
experts:
§
Kenneth Moch
(President and Chief Executive Officer, Cognition Therapeutics)
§
Mathias Schmidt
(Chief Executive Officer, ArmaGen)
§
Ram Bhatt (Chief
Executive Officer, Chairman and Founder, ICB International)
For additional
details, please visit
https://www.rootsanalysis.com/reports/view_document/alzheimers-disease-market/247.html or email sales@rootsanalysis.com
You may also be
interested in the following titles:
1.
Squamous
Non-Small Cell Lung Cancer Market, 2021-2031
2.
Novel
T-Cell Immunotherapies Market, 2021-2030
3.
HER2
Targeting Therapies Market, 2021-2030
About Roots Analysis
Roots Analysis is one of
the fastest growing market research companies, sharing fresh and independent
perspectives in the bio-pharmaceutical industry. The in-depth research,
analysis and insights are driven by an experienced leadership team which has
gained many years of significant experience in this sector. If you’d like help
with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis
Private Limited
Ben Johnson
+1 (415) 800 3415
Comments
Post a Comment